In order to develop a better dopamine receptor The homogenates from the human brain regions were prepared in the same way as those from the calf caudate, except that the preliminary crude homogenates of human brain were frozen in 1-ml aliquots, and after centrifugation they were resuspended in only 3 ml of buffer. Thus, the protein concentrations of both the human and calf homogenates were kept approximately equal. Optimum homogenization with the Polytron was obtained at a setting of 6 (for 20 sec) using a 16 X 100 mm glass test tube to hold the small 3-ml volume. Polytron settings greater than 6 (for 3 ml) caused a loss in binding sites; for calf homogenates, the optimum occurred at 7 (for 10 ml). (220), an aliquot of 0.5 ml was removed (polypropylene pipette tip) from the mixture and filtered under reduced pressure through a glass fiber filter (GF/B, Whatman, 24 mm diameter) using a Millipore stainless steel mesh support for the filter; the filtration took less than 1 sec. The filter was then washed twice with 5 ml of buffer per wash. The buffer was used at room temperature since minor differences in binding were found with the buffer at 40 or 37°. The wash buffer was delivered by gravity from a syringe Re-pipette over a period of 4 sec. The filters were not blotted or dried but placed directly into liquid scintillation vials; 8 ml of Aquasol (New England Nuclear Corp.) were added and the samples were monitored for 3H (25) after they were stored at 40 for at least 6 hr to allow temperature equilibration and to permit the glass fiber filters to become uniformly translucent. Specific binding of apomorphine was defined as that amount bound in the presence of 1 MM (-)-butaclamol minus that bound in the presence of 1 AM (+)-butaclamol, in accordance with previous work (7, 9) on dopamine receptors. The results were calculated in terms of femtomoles of apomorphine specifically bound per mg of homogenate protein. Apomorphine is sufficiently hydrophobic and surface-active to warrant measuring the unbound (free) concentration (26) (27) (28) 
ABSTRACI
In order to develop a better dopamine receptor 4 and 18 hr after death, and the entire brains were frozen until ready for frozen dissection, using the manual of Riley (20) . Putamen sample 75-62-29 was from a 29-year-old man (car accident); sample 75-63-67 was from a 67-year-old man (myocardial infarction); sample 75-61-45 was from a 45-year-old schizophrenic woman (suicide); sample 75-65-24 was from a 24-year-old man (suicide).
The homogenates from the human brain regions were prepared in the same way as those from the calf caudate, except that the preliminary crude homogenates of human brain were frozen in 1-ml aliquots, and after centrifugation they were resuspended in only 3 ml of buffer. Thus, the protein concentrations of both the human and calf homogenates were kept approximately equal. Optimum homogenization with the Polytron was obtained at a setting of 6 (for 20 sec) using a 16 X 100 mm glass test tube to hold the small 3-ml volume. Polytron settings greater than 6 (for 3 ml) caused a loss in binding sites; for calf homogenates, the optimum occurred at 7 (for 10 ml). (220), an aliquot of 0.5 ml was removed (polypropylene pipette tip) from the mixture and filtered under reduced pressure through a glass fiber filter (GF/B, Whatman, 24 mm diameter) using a Millipore stainless steel mesh support for the filter; the filtration took less than 1 sec. The filter was then washed twice with 5 ml of buffer per wash. The buffer was used at room temperature since minor differences in binding were found with the buffer at 40 or 37°. The wash buffer was delivered by gravity from a syringe Re-pipette over a period of 4 sec. The filters were not blotted or dried but placed directly into liquid scintillation vials; 8 ml of Aquasol (New England Nuclear Corp.) were added and the samples were monitored for 3H (25) after they were stored at 40 for at least 6 hr to allow temperature equilibration and to permit the glass fiber filters to become uniformly translucent. Specific binding of apomorphine was defined as that amount bound in the presence of 1 MM (-)-butaclamol minus that bound in the presence of 1 AM (+)-butaclamol, in accordance with previous work (7, 9) on dopamine receptors. The results were calculated in terms of femtomoles of apomorphine specifically bound per mg of homogenate protein. Apomorphine is sufficiently hydrophobic and surface-active to warrant measuring the unbound (free) concentration (26) (27) (28) binding was defined as that amount bound in the presence of (-)-butaclamol minus that amount bound in the presence of (+)-butaclamol (7). The total [3H]apomorphine concentration was 1.6 nM (free concentration was 0.91 nM). The GF/B filters had been washed once with 5 ml of buffer.
[3H]haloperidol to both filters and biomembranes. Both the wash volume and the filtration speed of the wash were found to be very critical in determining the amount of [3H]haloperidol specifically bound. The optimum speed of the 5-ml wash was between 2 and 3 sec. Haloperidol is strongly hydrophobic (29, 30) ; in the present experiments 50% of the total haloperidol was nonspecifically adsorbed.
RESULTS

Properties of Specific [3HjApomorphine
Binding. An example of both the total and specific components of [3H]apomorphine binding is given in Fig. 1 for different concentrations of (+)-and (-)-butaclamol. The (+)-enantiomer of butaclamol was 250 to 1000 times more effective than the (-)-enantiomer in reducing the total binding of [3H]apomorphine, in quantitative agreement with the enantiomeric potency ratio in vivo (21) (22) (23) and in vitro on the dopamine and neuroleptic receptor assays (7) . The nonspecific action of (-)-butaclamol started at about 1 ,M. Since maximum specific binding was almost attained at 1 ,M, it was decided to adhere to 1 AM (+)-and Fig. 2 Table 1 ). (D) Scatchard analysis of [3Hldopamine binding data (see Table 1 ).
is shown in Fig. 3 for nonradioactive apomorphine, which reduced the binding of [3H] Table 2 , together with those for [3H]dopamine. From these data it is possible to derive the dissociation constants of the inhibiting drugs (31) .
The neurotransmitter most effective in inhibiting the specific binding of [3H]apomorphine was dopamine ( Fig. 4 ; Table 1 ).
Norepinephrine had one-fourth the potency of dopamine, while epinephrine had one-fifth the potency of dopamine. All of the other neurotransmitters had no effect below 1 ,M. This order of potencies meets the criteria of a dopamine receptor, but not those of a beta-adrenergic receptor (32, 33) .
Another type of experiment was done that indicated that [3H]apomorphine was not binding to a beta-adrenergic receptor. We repeated the experiment in Fig. 1 
